Gonorrheal ophthalmia neonatorum: Historic impact of Credé’s eye prophylaxis

  • Axel Schmidt
Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)

Abstract

In the pre-antibiotic era gonorrhea showed a high prevalence also in industrialized countries. In Germany, more than 10% of all newborns developed gonorrheal ophthalmia neonatorum. Clinical courses of gonorrheal ophthalmia neonatorum were quite different in their severity but often caused significant impairment of eyesight up to total blindness in more than 5%. This accounted for 25–40% of cases of blindness in Germany. It was Carl Siegmund Franz Credé (1819–1892), a German obstetrician, who introduced the eye prophylaxis of eye drops containing 2% silver nitrate solution to every newborn child in his clinic in Leipzig on June 1st 1880. The incidence of gonorrheal ophthalmia neonatorum immediately decreased from 10% to 0%. Credé actively communicated these results and immediately published them in four publications within a time period of 3 years. These publications, which are discussed here, are written in a very pragmatic and strictly clinical style, ignoring new basic scientific insights into the microbiology of gonorrhea and the discovery of the corresponding pathogen, the “Micrococcus” by Albert Neisser, which Credé considered unimportant for his purposes. Against a high degree of opposition by many physicians, Credé put all enthusiasm into the call for education of midwives in this technique. Credé knew that this was the central way to ensure that all newborns could obtain this prophylaxis, including outpatients and home deliveries. Credé’s eloquence led to the rapid spreading of “his” eye prophylaxis over the rest of the world. The concentration of silver nitrate was often reduced from 2% to 1% thereafter and in most countries the performance of this prophylaxis was rapidly enforced by law. By introducing this method, Credé saved or improved the eyesight of millions of people — a significant contribution to obstetrics, neonatology and pediatrics, ophthalmology and mankind. Still today, in the antibiotic era, other topical regimens for antiseptic prophylaxis against ophthalmia neonatorum are often referred to as “Credé’s prophylaxis”.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO (2000) A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52: 662–668PubMedCrossRefGoogle Scholar
  2. 2.
    Quelmaltz ST (1740) De caecitate infantum floris albi materni ejusque virulanti pedisseque dissertatione. PhD Thesis, LeipzigGoogle Scholar
  3. 3.
    Gibson B (1807) On the common cause of puriform ophthalmia of new-born children. Edinburgh Med Surg J 3: 159–161Google Scholar
  4. 4.
    Ammon FA v (1825) Pathology of the eye bulbus and its adnexes during the illness entitled ophthalmitis of the new-born child (“Das pathologische Verhalten des Augapfels und seiner Häute während des Verlaufs der sogenannten Augenentzündung neugeborener Kinder”). In: Hecker’s Annalen, Vol 1, TCF Enslin, Berlin, 129–142Google Scholar
  5. 5.
    Bednar A (1848) Treatment of ophthalmia neonatorum (“Über die Behandlung der Augenentzündung der Neugeborenen”). Zschr k k Ges Ärzte 5: 139–145Google Scholar
  6. 6.
    Mackenzie W (1854) Practical Treatise on the Diseases of the Eye. Longmann, LondonGoogle Scholar
  7. 7.
    Noeggerath E (1872) Die latente Gonorrhoe im Weib (Latent Female Gonorrhea). Seiler, BonnGoogle Scholar
  8. 8.
    Oriel JD (1991) Eminent venerologists 5: Carl Credé. Genitourin Med 67: 67–69PubMedGoogle Scholar
  9. 9.
    Kibel MA (1981) Silver nitrate and the eyes of the newborn — a centennial. S Afr Med J 60: 979–980PubMedGoogle Scholar
  10. 10.
    Novak JM (1984) Current status of Credé prophylaxis. Am J Optometry Physiol Optics 61: 340–346Google Scholar
  11. 11.
    Schaller UC, Klauss V (2001) Is Credé’s prophylaxis for ophthalmia neonatorum still valid? Bull WHO 79: 262–263PubMedGoogle Scholar
  12. 12.
    Dunn PM (2000) Dr. Carl Credé (1819–1892) and the prevention of ophthalmia neonatorum. Arch Dis Child Fetal Neonatal Ed 83: 158–159CrossRefGoogle Scholar
  13. 13.
    Rosenberg J (1892) In memoriam, Carl Siegmund Franz Credé. Am J Obstet Gynecol 25: 780–783Google Scholar
  14. 14.
    Leopold G (1891) Talk in remembrance of Carl Siegmund Franz Credé (“Carl Siegmund Franz Credé. Gedächtnisrede”). Arch Gynäkol 42: 193–212CrossRefGoogle Scholar
  15. 15.
    Author unknown (Dr. L) (1892) Karl Credé. Illustrierte Zeitung, press release, no 2543Google Scholar
  16. 16.
    Credé CSF (1854) Manual expression of the placenta (“Handgriff zur Entfernung der Plazenta”). Klinische Vorträge über Geburtshilfe, Hirschwald, Berlin, 599–600Google Scholar
  17. 17.
    Speer H (1957) Carl Siegmund Credé, placental expression, and the prevention of ophthalmia neonatorum. Obstet Gynecol 10: 335–339Google Scholar
  18. 18.
    Credé CSF (1884) Incubation systems for early for date and weak small children (“Ueber Erwärmungsgeräthe für frühgeborene und schwächliche kleine Kinder”). Arch Gynäkol 24: 128–147CrossRefGoogle Scholar
  19. 19.
    Credé CSF (1881) Die Verhütung der Augenentzündung der Neugeborenen (“Prevention of inflammatory eye disease in the newborn”). Arch Gynäkol 17: 50–53CrossRefGoogle Scholar
  20. 20.
    Credé CSF (1881) Die Verhütung der Augenentzündung der Neugeborenen (“Prevention of inflammatory eye disease in the newborn”). Arch Gynäkol 18: 367–370CrossRefGoogle Scholar
  21. 21.
    Credé CSF (1883) Die Verhütung der Augenentzündung der Neugeborenen (“Prevention of inflammatory eye disease in the newborn”). Arch Gynäkol 21: 179–195CrossRefGoogle Scholar
  22. 22.
    Credé CSF (2001) Prevention of inflammatory eye disease in the new-born (“Die Verhütung der Augenentzündung der Neugeborenen”). Translation of [19] by WHO. Bull WHO 79: 265–266Google Scholar
  23. 23.
    Credé CSF (1884) Die Verhütung der Augenentzündung der Neugeborenen (“Prevention of Inflammatory Eye Disease in the Newborn”). Hirschwald, BerlinGoogle Scholar
  24. 24.
    Hecker C v (1882) On blephanorrhoea neonatorum (“Über Blephanorrhoea neonatorum”). Arch Gynäkol 20: 386–398CrossRefGoogle Scholar
  25. 25.
    Oriel JD (1989) Eminent venerologists. 1. Albert Neisser. Genitourin Med 65: 229–234PubMedGoogle Scholar
  26. 26.
    Scholz A, Wasik F (1985) Albert Neisser. Int J Dermatol 24: 373–377PubMedGoogle Scholar
  27. 27.
    http://www.onmeda.de/lexika/persoenlichkeiten/neisser/htmlGoogle Scholar
  28. 28.
    http://www.klinikum.uni-heidelberg.de/index.php?id=4114%20-%2017kGoogle Scholar
  29. 29.
    http://www.lexikon.donx.de/?action=detail­ow=Albert%20Neisserάrk=NeisserGoogle Scholar
  30. 30.
    http://www.whonamedit.com/doctor.cfm/2441.htmlGoogle Scholar
  31. 31.
    Kampmeier RH (1978) Identification of the gonococcus by Albert Neisser. 1879. Sex Trans Dis 5: 71–72CrossRefGoogle Scholar
  32. 32.
    Haneveld GT (1979) The centenary of the gonococcus: the importance of its discovery and the acknowledgement of this in The Netherlands (Ludwig Sigesmund Albert Neisser). Ned Tijdschr Geneeskd 123: 1875–1878PubMedGoogle Scholar
  33. 33.
    Neisser A (1879) A form of micrococcus typical for gonorrhea (“Über eine der Gonorrhoe eigenthümliche Micrococcenform”). Zentralbl Med Wissenschaften 17: 497–500Google Scholar
  34. 34.
    Neisser A (1882) Micrococci and gonorrhea (“Die Mikrokokken der Gonorrhoe”). Dtsch Med Wochenschr 8: 279–283CrossRefGoogle Scholar
  35. 35.
    Köhler W (1994) Historical development of medical microbiology (“Historische Entwicklung der Medizinischen Mikrobiologie”). In: H Brandis, HJ Eggers, W Köhler, G Pulverer (eds): Handbook of Medical Microbiology (“Lehrbuch der Medizinischen Mikrobiologie”). Fischer, Stuttgart, 3–17Google Scholar
  36. 36.
    Credé C, Winckel F (1875) Handbook for Midwives (“Lehrbuch der Hebammenkunst”). S. Hirzel, Leipzig, 117–118 / 237–243 (§§167, 358–3Google Scholar
  37. 37.
    Credé C, Leopold G (1892) Handbook of Obstetrics for Midwives (“Lehrbuch der Geburtshülfe für Hebammen”). S. Hirzel, Leipzig, 254–58 (§§ 358–3Google Scholar
  38. 38.
    Vail D (1963) Lucien Howe: the laboratory and experimental ophthalmology. Am J Ophthalmol 55: 261–279PubMedGoogle Scholar
  39. 39.
    Sullivan MF (1952) Silver acetate as a prophylactic for ophthalmia neonatorum. J Indian Med Assoc 21: 528–529Google Scholar
  40. 40.
    Cordell JPM (1936) Ophthalmia neonatorum. Trans Ophthalmol Soc UK 56: 3–7Google Scholar
  41. 41.
    Holmes KK, Counts GW, Beatty HN (1971) Disseminated gonococcal infection. Ann Intern Med 74: 979–993PubMedGoogle Scholar
  42. 42.
    Wilcox RR (1972) A world look at the venereal disease: recrudescence of the venereal diseases. Med Clin North Am 56: 1057–1071Google Scholar
  43. 43.
    Armstrong JH, Zacarias F, Rein MF (1976) Ophthalmia neonatorum: a chart review. Pediatrics 57: 884–892PubMedGoogle Scholar
  44. 44.
    Handsfield HH, Hodson KK (1973) Neonatal gonococcal infection: orogastric contamination with Neisseria gonorrhoeae. J Am Med Assoc 225: 697–701CrossRefGoogle Scholar
  45. 45.
    Huber-Spitzy V, Arocker W, Schmidt C (1987) Ophthalmia neonatorum. Klin Mbl Augenheilk 191: 341–343PubMedGoogle Scholar
  46. 46.
    Lehrfeld L (1935) Limitations of use of silver nitrate in prevention of ophthalmia neonatorum. J Am Med Assoc 104: 1468–1469Google Scholar
  47. 47.
    Robson KS (1967) The role of the eye-to-eye contact in maternal-infant attachment. J Child Psychol Psychiatry 8: 13–25PubMedCrossRefGoogle Scholar
  48. 48.
    Nishida H, Risemberg HM (1975) Silver nitrate ophthalmic solution and chemical conjunctivitis. Pediatrics 56: 368–373PubMedGoogle Scholar
  49. 49.
    Butterfield PM, Emde RN, Svejda MJ (1981) Does the early application of silver nitrate impair maternal attachment? Pediatrics 67: 737–738PubMedGoogle Scholar
  50. 50.
    Graf H, Retzke U, Schilling C, Schmidt M (1994) Reaction of the ophthalmic front region to the Credé-prophylaxis (“Die Reaktion des vorderen Augenabschnittes auf die Credé-Prophylaxe”). Zentralbl Gynäkol 116: 639–642PubMedGoogle Scholar
  51. 51.
    Greenberg M, Vandow JE (1961) Ophthalmia neonatorum: evaluation of different methods of prophylaxis in New York City. Am J Public Health 51: 836–845CrossRefGoogle Scholar
  52. 52.
    CDC (Centers for Disease Control) (1989) Sexually transmitted diseases treatment guidelines. MMWR 38: 8Google Scholar
  53. 53.
    Chen JY (1992) Prophylaxis of ophthalmia neonatorum: comparison of silver nitrate, tetracycline, erythromycin and no prophylaxis. Pediatr Infect Dis J 11: 1026–1030PubMedGoogle Scholar
  54. 54.
    Seiga K, Shoji T (1993) Chemoprophylaxis of ophthalmia neonatorum through vertical infection. Evaluation of Crede’s method using norfloxacin and gentamycin. Jpn J Antibiot 46: 331–336PubMedGoogle Scholar
  55. 55.
    Kramer A, Behrens-Baumann W (1997) Prophylactic use of topical anti-infectives in ophthalmology. Ophthalmologica 211(S1): 68–76PubMedCrossRefGoogle Scholar
  56. 56.
    Benevento WJ, Murray P, Reed CA, Pepose JS (1990) The sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and herpes simplex type II to disinfection with povidone-iodine. Am J Ophthalmol 109: 329–333PubMedGoogle Scholar
  57. 57.
    Isenberg SJ, Apt L, Yoshimori R, Leake RD, Rich R (1994) Povidone-iodine for ophthalmia neonatorum prophylaxis. Am J Ophthalmol 118: 701–706PubMedGoogle Scholar
  58. 58.
    Isenberg SJ, Apt L, Wood M (1995) A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med 332: 562–566PubMedCrossRefGoogle Scholar
  59. 59.
    Reimer K, Fleischer W, Brogmann B, Schreier H, Burkhard P, Lanzendorfer A, Gumbel H, Hoekstra H, Behrens-Baumann W (1997) Povidone-iodine liposomes — an overview. Dermatology 195(S2): 93–99PubMedCrossRefGoogle Scholar
  60. 60.
    Kramer A, Below H, Behrens-Baumann W, Muller G, Rudolph P, Reimer K (2002) New aspects of the tolerance of povidone-iodine in different ex vivo models. Dermatology 204(S1): 86–91PubMedCrossRefGoogle Scholar
  61. 61.
    Isenberg SJ, Apt L, Campeas D (2002) Ocular applications of povidone-iodine. Dermatology 204(S1): 92–95PubMedCrossRefGoogle Scholar
  62. 62.
    Simon JW (2003) Povidone-iodine prophylaxis of ophthalmia neonatorum. Br J Ophthalmol 87: 1437PubMedCrossRefGoogle Scholar
  63. 63.
    Isenberg SJ, Apt L, Del Signore M, Gichuhi S, Bermann NG (2003) A double application approach to ophthalmia neonatorum prophylaxis. Br J Ophthalmol 87: 1449–1452PubMedCrossRefGoogle Scholar
  64. 64.
    The Editorial Board (1980) Centenary of Credé prophylaxis. Am J Ophthalmol 90: 874–875Google Scholar
  65. 65.
    Tietze KW (1994) Credé’s prophylaxis. Report of a commission of the German Authority of Health (“Die Credé Prophylaxe. Bericht einer Kommission des Bundesgesundheitsamtes”). Ophthalmologe 91: 551–552PubMedGoogle Scholar
  66. 66.
    Watten RG (1994) Reinvention of visual fatigue: accumulation of scientific knowledge or neglect of scientific history? Ophthalmic Physiol Opt 14: 428–432PubMedCrossRefGoogle Scholar
  67. 67.
    Editorial Board (2002) New aspects in prophylaxis of ophthalmia neonatorum (Credé prophylaxis). Wien Klin Wochenschr 114: 171–172Google Scholar
  68. 68.
    Laga M, Meheus A, Piot P (1989) Epidemiology and control of gonococcal ophthalmia neonatorum. Bull WHO 67:471–477 [Erratum: Bull WHO (1990) 68: 690]PubMedGoogle Scholar
  69. 69.
    Gilbert C, Foster A (2001) Childhood blindness in the context of VISION 2020 — The Right to Sight. Bull WHO 79: 227–232; http://www.scielosp.org/scielo.php?pid=S004296862000100300011&script=sci_arttext&tlng=enPubMedGoogle Scholar
  70. 70.
    http://www.matrikel.unizh.ch/pages/45.htmGoogle Scholar
  71. 71.
    http://www.internet-taubenschlag.de/medizin/bericht7Google Scholar
  72. 72.
    http://www.uni-kiel.de/anorg/lagaly/group/klausSchiver/Lottermoser.pdfGoogle Scholar
  73. 73.
    Hille M (1897) On Dr. Credé’s Antiseptics: Silver and Silver-Salts and their Usage within Dental Medicine (“Ueber Dr. Credé’s neue Antiseptica: Silber und Silbersalze und deren Anwendung in der Zahnheilkunde”). “Separatabdruck” (Reprint) from Deutsche Monatsschrift für Zahnheilkunde 15(5). A. Pries, Leipzig, 1–9Google Scholar
  74. 74.
    Beyer JL (1904) Use of Kolloidal Metalls in Medicine: Silver and Mercury (“Über die Verwendung kolloider Metalle — Silber und Quecksilber — in der Medizin”). L. Simion, Berlin, GermanyGoogle Scholar
  75. 75.
    http://www.whonamedit.com/doctor.cfm/2028.htmlGoogle Scholar
  76. 76.
    Albrecht B, Albrecht G (1989) Carl Credé, 1878–1952, an unjustifiedly accused physician (“Carl Credé, 1878–1952, als Arzt unschuldig verurteilt”). In: B Albrecht, G Albrecht (eds): Diagnoses. Remembrances on Physician of the 20th Century (“Diagnosen. Ärzteerinnerungen aus dem 20. Jahrhundert”). Der Morgen, Berlin, 294–307Google Scholar
  77. 77.
    Albrecht B, Albrecht G (1989) Carl Credé. In: Albrecht B, Albrecht G (eds): Diagnoses. Remembrances on physician of the 20th century (“Diagnosen. Ärzteerinnerungen aus dem 20. Jahrhundert”). Der Morgen, Berlin, 416–417Google Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2007

Authors and Affiliations

  • Axel Schmidt
    • 1
  1. 1.Axel Schmidt, Institute of Microbiology and Virology, Faculty of MedicineUniversity Witten/HerdeckeWittenGermany

Personalised recommendations